Medtronic plc (VIE:MDT)
Austria · Delayed Price · Currency is EUR | Market Cap | 100.23B -7.0% |
| Revenue (ttm) | 32.64B +9.8% |
| Net Income | 4.55B +12.3% |
| EPS | 3.53 +12.1% |
| Shares Out | n/a |
| PE Ratio | 22.04 |
| Forward PE | 14.61 |
| Dividend | 2.48 (3.18%) |
| Ex-Dividend Date | Sep 25, 2026 |
| Volume | n/a |
| Open | 76.36 |
| Previous Close | 77.34 |
| Day's Range | 76.36 - 78.08 |
| 52-Week Range | 63.38 - 91.24 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 24, 2026 |
About Medtronic
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and rem... [Read more]
Financial Performance
In fiscal year 2026, Medtronic's revenue was $36.36 billion, an increase of 8.43% compared to the previous year's $33.54 billion. Earnings were $4.80 billion, an increase of 2.98%.
Financial numbers in USD Financial StatementsNews
Medtronic Announces Final Exchange Ratio of 4.5939 in Split-Off of MiniMed Group, Inc.
GALWAY, Ireland, Oct. 7, 2026 /PRNewswire/ -- Medtronic plc (Medtronic; NYSE: MDT) today announced the final exchange ratio for its previously announced offer to exchange outstanding Medtronic ordinar...
Why Medtronic's $4 Billion MiniMed Exchange Offer Is Losing Its Allure
The tax-free exchange offer allows Medtronic investors to swap their shares for MiniMed shares held by Medtronic in what Wall Street calls a split-off.
Medtronic Receives Category I CPT® Code Approvals for Altaviva™ and Symplicity Spyral™ Systems
Coding approvals reflect growing clinical evidence and physician adoption of Medtronic solutions addressing urge urinary incontinence and hypertension GALWAY, Ireland, Oct. 1, 2026 /PRNewswire/ -- Me...
Medtronic announces regulatory milestones for newest cardiac mapping and ablation software
FDA clearance and CE Mark for latest Affera™ Prism-2 Mapping Software expand cardiac mapping capabilities CE Mark for PulseSelect ProxBox™ Adapter with Proximity Indicator software adds real-time tiss...
Medtronic announces FDA clearance for LigaSure™ RAS Maryland instrument on the Hugo™ RAS system
Trusted vessel-sealing technology used in more than 45 million procedures worldwide is now cleared for robotic-assisted surgery in the U.S. GALWAY, Ireland, Sept. 16, 2026 /PRNewswire/ -- Medtronic (N...
Medtronic Transcript: Morgan Stanley 24th Annual Global Healthcare Conference
Strong acute procedure volumes, AI-driven innovation, and robust growth in key franchises are fueling sustained top-line expansion. Strategic investments in robotics and portfolio optimization, along with operational improvements, support margin expansion and a positive outlook, with further details expected at the upcoming Investor Day.
Medtronic Launches Exchange Offer to Complete Separation of MiniMed Group, Inc.
Medtronic shareholders can exchange their Medtronic ordinary shares for shares of MiniMed Provides Medtronic shareholders with option for a generally tax-free exchange for U.S. federal income tax pu...
MiniMed Files Form S-4 Registration Statement in Connection with Medtronic Exchange Offer Announcement
NORTHRIDGE, Calif., Sept. 14, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED) announced that it has filed a Form S-4 Registration Statement today with the Securities and Exchange Commission (the "SEC") in...
Jim Cramer says investors are too focused on AI stocks. Here's where he says to look instead
CNBC's Jim Cramer said investors should look beyond the AI data-center trade as compelling opportunities emerge in other areas of the market. He highlighted aerospace, fintech, health care and energy ...
Medtronic Transcript: Wells Fargo 21st Annual Healthcare Conference
MedTech innovation is accelerating, driven by AI, robotics, and new therapies that expand patient access and improve outcomes. Strong Q1 growth is supported by high-performing franchises and investments, with Cardiac Ablation, hypertension, and surgical robotics as key drivers. The company will detail new opportunities at its upcoming Investor Day.
Teleflex Appoints Veteran Medical Technology Executive Sean M. Salmon to Teleflex Board of Directors
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced the appointment of Sean M. Salmon to its Board of Directors, effective...
Medtronic executives to speak at upcoming investor conferences
GALWAY, Ireland, Sept. 4, 2026 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the following investor conferences: 2026 Wells...
Medtronic CEO Martha on beating estimates in Q1: Driven by growth across many of our businesses
Geoff Martha, Medtronic CEO, joins 'Squawk on the Street' to discuss shares rising Tuesday after the company announced a $700 million investment in Cornerstone Robotics, a robotic surgical company.
Medtronic Lifts Outlook, Invests Over $700 Million in Heart Tech & Robotics
Medtronic raised its outlook for the year after posting higher fiscal first-quarter profit and sales, driven by broad-based demand and contributions from newer growth platforms.
Medtronic Earnings Call Transcript: Q1 2027
Q1 FY27 saw 13.7% organic revenue growth to $9.8B and adjusted EPS of $1.45, with broad-based strength across major business units and significant contributions from CAS, Altaviva, and robotics. FY27 guidance was raised for both revenue and EPS, supported by strong execution and innovation.
Medtronic Earnings release: Q1 2027
Medtronic released its Q1 2027 earnings on September 1, 2026, summarizing the period's financial results.
Medtronic Slides: Q1 2027
Medtronic has posted slides in relation to its Q1 2027 quarterly earnings report, which was published on September 1, 2026.
Medtronic Quarterly report: Q1 2027
Medtronic has published its Q1 2027 quarterly earnings report on September 1, 2026.
Medtronic Stock Rises on Better-Than-Expected Earnings and $700 Million Investment in a Robot Surgeon
Medtronic stock advances after the company posts better-than-expected quarterly earnings, raises revenue guidance, and announces a $700 million investment.
Medtronic boosts fiscal 2027 forecasts on heart device demand
Medtronic raised the lower end of its fiscal 2027 profit forecast and revenue growth outlook on Tuesday, banking on strong demand for its heart devices used in complex cardiovascular procedures.
Medtronic reports first quarter fiscal 2027 results; delivers broad-based portfolio performance and raises fiscal 2027 guidance
Strength across the company's largest franchises, new growth platforms, and recent portfolio investments support the long-term growth trajectory GALWAY, Ireland, Sept. 1, 2026 /PRNewswire/ -- Medtroni...
Medtronic Announces Strategic Partnership with Cornerstone Robotics to Further Expand Global Access to Robotic-Assisted Surgery
Partnership expands Medtronic's robotic-assisted surgery portfolio to expand access globally and gives surgeons and health systems more choice and flexibility $700 million investment includes rights t...
Medtronic Announces Strategic Investment in Pi-Cardia to Accelerate Innovation for Complex TAVR
GALWAY, Ireland and REHOVOT, Israel, Sept. 1, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, and Pi-Cardia Ltd.